Cargando…

PEGylated SLN as a Promising Approach for Lymphatic Delivery of Gefitinib to Lung Cancer

PURPOSE: The present study aimed to develop gefitinib-loaded solid lipid nanoparticles (GEF-SLN), and GEF-loaded PEGylated SLN (GEF-P-SLN) for targeting metastatic lung cancer through the lymphatic system. METHODS: The prepared SLNs were characterized in terms of physicochemical properties, entrapme...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sherif, Abdelrahman Y, Harisa, Gamaleldin I, Alanazi, Fars K, Nasr, Fahd A, Alqahtani, Ali S
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2022
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9342893/ https://www.ncbi.nlm.nih.gov/pubmed/35924261 http://dx.doi.org/10.2147/IJN.S365974

Ejemplares similares

Engineered Nanoscale Lipid-Based Formulation as Potential Enhancer of Gefitinib Lymphatic Delivery: Cytotoxicity and Apoptotic Studies Against the A549 Cell Line
por: Sherif, Abdelrahman Y., et al.
Publicado: (2022)

Hybrid Lymphatic Drug Delivery Vehicles as a New Avenue for Targeted Therapy: Lymphatic Trafficking, Applications, Challenges, and Future Horizons
por: Harisa, Gamaleldin I., et al.
Publicado: (2023)

Optimization of Gefitinib-Loaded Nanostructured Lipid Carrier as a Biomedical Tool in the Treatment of Metastatic Lung Cancer
por: Sherif, Abdelrahman Y., et al.
Publicado: (2023)

Low density lipoprotein bionanoparticles: From cholesterol transport to delivery of anti-cancer drugs
por: Harisa, Gamaleldin I., et al.
Publicado: (2013)

Developed simvastatin chitosan nanoparticles co-crosslinked with tripolyphosphate and chondroitin sulfate for ASGPR-mediated targeted HCC delivery with enhanced oral bioavailability
por: Faris, Tarek M., et al.
Publicado: (2020)

The beneficial roles of Lupineus luteus and lifestyle changes in management of metabolic syndrome: A case study
por: Harisa, Gamaleldin I., et al.
Publicado: (2015)

Erythrocyte nanovesicles: Biogenesis, biological roles and therapeutic approach: Erythrocyte nanovesicles
por: Harisa, Gamaleldin I., et al.
Publicado: (2017)

Pravastatin chitosan nanogels-loaded erythrocytes as a new delivery strategy for targeting liver cancer
por: Harisa, Gamaleldin I., et al.
Publicado: (2016)

Design and encapsulation of anticancer dual HSP27 and HER2 inhibitor into low density lipoprotein to target ovarian cancer cells
por: Alhadad, Laila J., et al.
Publicado: (2020)

Enhanced Codelivery of Gefitinib and Azacitidine for Treatment of Metastatic-Resistant Lung Cancer Using Biodegradable Lipid Nanoparticles
por: Elzayat, Ehab M., et al.
Publicado: (2023)

Chitosan treatment abrogates hypercholesterolemia-induced erythrocyte’s arginase activation
por: Harisa, Gamaleldin I., et al.
Publicado: (2017)

Crosstalk of low density lipoprotein and liposome as a paradigm for targeting of 5-fluorouracil into hepatic cells: cytotoxicity and liver deposition
por: Alanazi, Saleh A., et al.
Publicado: (2021)

Bioactive Self-Nanoemulsifying Drug Delivery Systems (Bio-SNEDDS) for Combined Oral Delivery of Curcumin and Piperine
por: Kazi, Mohsin, et al.
Publicado: (2020)

Development, Characterization Optimization, and Assessment of Curcumin-Loaded Bioactive Self-Nanoemulsifying Formulations and Their Inhibitory Effects on Human Breast Cancer MCF-7 Cells
por: Kazi, Mohsin, et al.
Publicado: (2020)

Spherical inversion on SLn(R)
por: Jorgenson, Jay, et al.
Publicado: (2001)

Chitosan-Coated SLN: A Potential System for Ocular Delivery of Metronidazole
por: Sikhondze, Simise S., et al.
Publicado: (2023)

Characterization of Human Erythrocytes as Potential Carrier for Pravastatin: An In Vitro Study
por: Harisa, Gamal El-din I., et al.
Publicado: (2011)

Preparation and Optimization of PEGylated Nano Graphene Oxide-Based Delivery System for Drugs with Different Molecular Structures Using Design of Experiment (DoE)
por: Shariare, Mohammad Hossain, et al.
Publicado: (2021)

Novel in-situ gel for intravesical administration of ketorolac
por: Sherif, Abdelrahman Y., et al.
Publicado: (2018)

Current State-of-Art and New Trends on Lipid Nanoparticles (SLN and NLC) for Oral Drug Delivery
por: Severino, Patrícia, et al.
Publicado: (2012)

Physicochemical and biopharmaceutical aspects influencing skin permeation and role of SLN and NLC for skin drug delivery
por: Souto, Eliana B., et al.
Publicado: (2022)

Optimization of the Conditions of Solid Lipid Nanoparticles (SLN) Synthesis
por: Musielak, Ewelina, et al.
Publicado: (2022)

Valsartan prevents gefitinib-induced lung inflammation, oxidative stress, and alteration of plasma metabolites in rats
por: Alanazi, Wael A., et al.
Publicado: (2023)

Development, Characterization, and Evaluation of SLN-Loaded Thermoresponsive Hydrogel System of Topotecan as Biological Macromolecule for Colorectal Delivery
por: Xing, R., et al.
Publicado: (2021)

Solid Lipid Nanoparticles (SLN) and Nanostructured Lipid Carriers (NLC) Prepared by Microwave and Ultrasound-Assisted Synthesis: Promising Green Strategies for the Nanoworld
por: López, Karla L., et al.
Publicado: (2023)

Delivery of gefitinib with an immunostimulatory nanocarrier improves therapeutic efficacy in lung cancer
por: Diao, Dingwei, et al.
Publicado: (2021)

Evidence of Th2 polarization of the sentinel lymph node (SLN) in melanoma
por: Grotz, Travis E, et al.
Publicado: (2015)

SLN as a topical delivery system for Artemisia arborescens essential oil: In vitro antiviral activity and skin permeation study
por: Lai, Francesco, et al.
Publicado: (2007)

Novel oral dosage regimen based on self-nanoemulsifying drug delivery systems for codelivery of phytochemicals – Curcumin and thymoquinone
por: Alwadei, Majed, et al.
Publicado: (2019)

PEGylated versus non-PEGylated magnetic nanoparticles as camptothecin delivery system
por: Castillo, Paula M, et al.
Publicado: (2014)

A promising gene delivery system developed from PEGylated MoS(2) nanosheets for gene therapy
por: Kou, Zhongyang, et al.
Publicado: (2014)

Importance of solid lipid nanoparticles (SLN) in various administration routes and future perspectives
por: Üner, Melike, et al.
Publicado: (2007)

Edible solid lipid nanoparticles (SLN) as carrier system for antioxidants of different lipophilicity
por: Oehlke, Kathleen, et al.
Publicado: (2017)

Increased Therapeutic Efficacy of SLN Containing Etofenamate and Ibuprofen in Topical Treatment of Inflammation
por: Mancini, Giuliana, et al.
Publicado: (2021)

Knockdown of sarcolipin (SLN) impairs substrate utilization in human skeletal muscle cells
por: Mengeste, Abel M., et al.
Publicado: (2022)

Promising PEGylated cationic dendrimers for delivery of miRNAs as a possible therapy against HIV-1 infection
por: Royo-Rubio, E., et al.
Publicado: (2021)

SLN melanoma micrometastasis predictivity of nodal status: a long term retrospective study
por: Migliano, Emilia, et al.
Publicado: (2013)

Evaluation of the antibacterial activity of tilmicosin-SLN against Streptococcus agalactiae: in vitro and in vivo studies
por: Zhu, Luyan, et al.
Publicado: (2018)

Techniques and Current Role of Sentinel Lymph Node (SLN) Concept in Gastric Cancer Surgery
por: Symeonidis, Dimitrios, et al.
Publicado: (2019)

Chloroquine Enhances Gefitinib Cytotoxicity in Gefitinib-Resistant Nonsmall Cell Lung Cancer Cells
por: Tang, Mei-Chuan, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_3liu9ucetq7e04pebt6f1j541e